Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
N Hyman, M Barnes, B Bhakta, A Cozens, M Bakheit, B Kreczy-Kleedorfer, W Poewe, J Wissel, P Bain, S Glickman, A Sayer, A Richardson, C Dott
Journal of Neurology, Neurosurgery & Psychiatry Jun 2000, 68 (6) 707-712; DOI: 10.1136/jnnp.68.6.707